Spruce Point Capital warned iRhythm Technologies could face a 40%–70% stock decline, citing regulatory risks and product safety issues.
Investor Short Report Flags Steep Downside Risk For iRhythm Technologies (CORRECTED)
Where Today's News Shapes Tomorrow
